[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Primary Biliary Cirrhosis Drug Market Report 2018

June 2018 | 100 pages | ID: AB054717FF3EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Primary Biliary Cirrhosis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Primary Biliary Cirrhosis Drug for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Primary Biliary Cirrhosis Drug market competition by top manufacturers/players, with Primary Biliary Cirrhosis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AlbireoPharma
  • CymaBay Therapeutics, Inc.
  • Dr. Falk Pharma GmbH
  • Enanta Pharmaceuticals, Inc.
  • GlaxoSmithKline Plc
  • Intercept Pharmaceuticals, Inc.
  • Johnson & Johnson
  • MediGene AG
  • NGM Biopharmaceuticals, Inc.
  • Virobay Inc.
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Budesonide
  • FFP-104
  • GSK-2330672
  • MBX-8025
  • NGM-282
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
Asia-Pacific Primary Biliary Cirrhosis Drug Market Report 2018

1 PRIMARY BILIARY CIRRHOSIS DRUG OVERVIEW

1.1 Product Overview and Scope of Primary Biliary Cirrhosis Drug
1.2 Classification of Primary Biliary Cirrhosis Drug by Product Category
  1.2.1 Asia-Pacific Primary Biliary Cirrhosis Drug Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Primary Biliary Cirrhosis Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Budesonide
  1.2.4 FFP-104
  1.2.5 GSK-2330672
  1.2.6 MBX-8025
  1.2.7 NGM-282
  1.2.8 Others
1.3 Asia-Pacific Primary Biliary Cirrhosis Drug Market by Application/End Users
  1.3.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Asia-Pacific Primary Biliary Cirrhosis Drug Market by Region
  1.4.1 Asia-Pacific Primary Biliary Cirrhosis Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Primary Biliary Cirrhosis Drug (2013-2025)
  1.5.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC PRIMARY BILIARY CIRRHOSIS DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Primary Biliary Cirrhosis Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Primary Biliary Cirrhosis Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Primary Biliary Cirrhosis Drug (Volume) by Application
2.4 Asia-Pacific Primary Biliary Cirrhosis Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Market Share by Region (2013-2018)

3 CHINA PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  3.1.1 China Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  3.1.3 China Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
3.2 China Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
3.3 China Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

4 JAPAN PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  4.1.1 Japan Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
4.2 Japan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
4.3 Japan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

5 SOUTH KOREA PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  5.1.1 South Korea Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
5.2 South Korea Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
5.3 South Korea Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

6 TAIWAN PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  6.1.1 Taiwan Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
6.2 Taiwan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
6.3 Taiwan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

7 INDIA PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  7.1.1 India Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  7.1.3 India Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
7.2 India Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
7.3 India Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  8.1.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
8.2 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

9 AUSTRALIA PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Primary Biliary Cirrhosis Drug Sales and Value (2013-2018)
  9.1.1 Australia Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Primary Biliary Cirrhosis Drug Sales Price Trend (2013-2018)
9.2 Australia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
9.3 Australia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC PRIMARY BILIARY CIRRHOSIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AlbireoPharma
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 CymaBay Therapeutics, Inc.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Dr. Falk Pharma GmbH
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Enanta Pharmaceuticals, Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 GlaxoSmithKline Plc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Intercept Pharmaceuticals, Inc.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Johnson & Johnson
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 MediGene AG
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 NGM Biopharmaceuticals, Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Virobay Inc.
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview

11 PRIMARY BILIARY CIRRHOSIS DRUG MANUFACTURING COST ANALYSIS

11.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PRIMARY BILIARY CIRRHOSIS DRUG MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Primary Biliary Cirrhosis Drug Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Primary Biliary Cirrhosis Drug Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Primary Biliary Cirrhosis Drug Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Primary Biliary Cirrhosis Drug
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Budesonide Product Picture
Figure FFP-104 Product Picture
Figure GSK-2330672 Product Picture
Figure MBX-8025 Product Picture
Figure NGM-282 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Primary Biliary Cirrhosis Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size (Million USD) by Region (2013-2025)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Major Players Product Sales Volume (K Pcs)(2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Primary Biliary Cirrhosis Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Share by Players
Figure 2017 Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Share by Players
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Type (2013-2018)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Type (2013-2018)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Region (2013-2018)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Market Share by Region in 2017
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Region (2013-2018)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Market Share by Region in 2017
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Market Share by Application (2013-2018)
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table China Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Figure Japan Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table Japan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Figure South Korea Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure South Korea Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table South Korea Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table South Korea Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure South Korea Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table South Korea Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table South Korea Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure South Korea Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Figure Taiwan Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Taiwan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Taiwan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Taiwan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table Taiwan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Taiwan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Figure India Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table India Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Figure Australia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Australia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Australia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Australia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2013-2018)
Figure Australia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2017
Table Australia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Australia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2013-2018)
Figure Australia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2017
Table AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information List
Table AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information List
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information List
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Basic Information List
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table MediGene AG Primary Biliary Cirrhosis Drug Basic Information List
Table MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Biliary Cirrhosis Drug
Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
Figure Primary Biliary Cirrhosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2017
Table Major Buyers of Primary Biliary Cirrhosis Drug
Table Distributors/Traders List
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Region in 2025
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South Korea Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Taiwan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Australia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories